Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$2.28 USD
+0.02 (0.88%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/9/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | -16.67% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.28 |
Next Year | -2.32 |
EPS (TTM) | -1.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.26 | -1.28 | -2.32 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.28 | -0.26 | -1.28 | -2.32 |
High Estimate | -0.28 | -0.26 | -1.28 | -2.32 |
Low Estimate | -0.28 | -0.26 | -1.28 | -2.32 |
Year ago EPS | -0.28 | -0.24 | -1.15 | -1.28 |
Year over Year Growth Est. | 0.00% | -8.33% | -11.30% | -81.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.26 | -1.28 | -2.32 |
7 Days Ago | -0.28 | -0.26 | -1.28 | -2.32 |
30 Days Ago | -0.28 | -0.26 | -1.28 | -2.32 |
60 Days Ago | -0.28 | -0.26 | -1.28 | -2.32 |
90 Days Ago | -0.20 | -0.18 | -0.97 | -2.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.26 | -1.28 | -2.32 |
Zacks Consensus Estimate | -0.28 | -0.26 | -1.28 | -2.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.38 | -0.24 | -0.28 | NA |
Estimate | -0.24 | -0.26 | -0.28 | -0.29 | NA |
Difference | -0.04 | -0.12 | 0.04 | 0.01 | -0.03 |
Surprise | -16.67% | -46.15% | 14.29% | 3.45% | -11.27% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more